Drug Profile
Research programme: NASH gene therapy - Amsterdam Molecular Therapeutics
Alternative Names: AMT-012Latest Information Update: 16 Jul 2012
Price :
$50
*
At a glance
- Originator Amsterdam Molecular Therapeutics
- Class Gene therapies
- Mechanism of Action Gene transference
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Non-alcoholic steatohepatitis
Most Recent Events
- 18 Nov 2009 No development reported for Non-alcoholic steatohepatitis in Netherlands (Parenteral)
- 25 May 2009 Early research in Non-alcoholic steatohepatitis in Netherlands (Parenteral)